The market for immune health supplement is expected to grow at a CAGR of around 6.6% from 2020 to 2027 and expected to reach the market value of around US$ 28.1 Bn by 2027.
Immune health supplements are the nutrient supplements or combination of them based on animal or plant extracts, particularly manufactured to boost immunity.
The rising consumer know-how regarding the bolstering of daily health issues due to changing lifestyles, increasing pollutions, and unhealthy eating habits are driving the demand for immune health supplements in the global market. The increasing popularity of wellness trends, reference for personalized nutrition is one of the key trends in the global immune health supplement market. The increasing demand for personalized supplements is also bolstering the market value, as the gut-related medical conditions are where generic treatment is not effective and requires personalized nutrition. Furthermore, the introduction of new delivery formats and scientific evidence to support the claims is another strong factor boosting the market growth.
On the other side, lack of consumer awareness in some economies across the globe and side effects associated with the supplements without proper usage are likely to restrict the growth over the estimated period from 2020 to 2027.
Covid-19 impact on the Immune Health Supplement Market
The spread of coronavirus across the globe has given a major boost to the immune health supplement particularly in the financial year 2020. People with low immunity power are highly prone to the virus illness when exposed. This has raised awareness among the people about the string immunity power and has also boosted the immunity supplements demand among them. The increasing number of initiatives from the government and other healthcare authorities to raise awareness about the proper care of the immune system is further bolstering the market growth.
Segment Instance of Global Immune Health Supplement Market
Vitamins & Minerals segment accounted for the maximum revenue share in the global immune health supplements market
On the basis of product type, the vitamins & minerals segment is having a potential share in the global immune health supplements market. The benefits associated with the vitamins & minerals for every age group are the major factor contributing to the segmental market value.
North America accounted for the maximum revenue share in the Immune Health Supplement Market
In 2019, North America leads the immune health supplement market and the region is also projected to maintain its dominance throughout the forecast period from 2020 to 2027. The major economies of the region including the US and Canada are contributing to the maximum revenue share. The coronavirus pandemic has also given a boost to the regional market value due to the increasing demand for supplements from the residents and especially from the geriatric population.
Asia Pacific is anticipated to exhibit fastest growth during the forecast period from 2020 to 2027
Asia Pacific region is projected to experience the fastest growth along with its major developing economies during the forecast period from 2020 to 2027. The risk associated with the degrading health condition with aging is primarily supporting the demand for supplements in the regional market. Majorly, the rising awareness among the people about the supplements due to growing economic condition and spending power of residents with it is boosting the regional market growth.
Key Marker Players
The players profiled in the report include Amway Corp, Bayer AG, Bio-Tech Pharmacal, BioGaia, Cellderm Technologies Inc., Daflorn Ltd., EuroPharma, Inc., Glanbia, Plc, Koninklijke DSM N.V., NOW Foods, NutriGold Inc, Seroyal, The Himalayan Drug Company, and Vital Nutrients among others
Market By Product Type
Vitamins & Minerals
Omega-3 Fatty Acids
Market By Source
Market By Format
Market By Distribution Channel
Supermarkets and Hypermarkets
Pharmacies & drug stores
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
The market for immune health supplement is expected to reach a market value of around US$ 28.1 Bn by 2027.
The immune health supplement market is expected to grow at a CAGR of around 6.6% from 2020 to 2027.
The vitamins & minerals is the leading segment by product type in the immune health supplement market
The rising consumer know-how regarding the bolstering daily health issues, increasing popularity of wellness trends, reference for personalized nutrition, and ageing population is majorly supporting the demand for immune based health supplements in the global market.
Amway Corp, Bayer AG, Bio Tech Pharmacal, BioGaia, Cellderm Technologies Inc., Daflorn Ltd., EuroPharma, Inc., Glanbia, Plc, Koninklijke DSM N.V., NOW Foods, NutriGold Inc, Seroyal, The Himalayan Drug Company, and Vital Nutrients among others are the prominent players in the immune health supplement market.
North America held the highest market share in the immune health supplement market
Asia Pacific is expected to be the fastest growing market over the forecast period